Brighton Jones’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding GLUE
Brighton Jones's GLUE Position: Q3 2026 in Review
Brighton Jones sold out of Monte Rosa Therapeutics (GLUE) in Q3 2026, closing a stake of 9,746 shares — an estimated $236K sold.
Brighton Jones first reported a position in GLUE in Q2 2025 and held it in 3 quarters. The position peaked at $236K in Q2 2026. 142 funds tracked by Wall St. Rank hold GLUE as of Q3 2026.
- Brighton Jones reported no remaining Monte Rosa Therapeutics position as of Q3 2026 after selling out during the quarter.
- Brighton Jones sold 9,746 Monte Rosa Therapeutics shares in Q3 2026, an estimated $236K.
- Brighton Jones first reported a position in Monte Rosa Therapeutics in Q2 2025 and held it in 3 quarters.
- Brighton Jones's Monte Rosa Therapeutics position peaked at $236K in Q2 2026.
- 142 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.